AI-assisted diagnosis of brain tumors
Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial tests an AI tool that helps diagnose brain tumors like glioma, brain metastases, and lymphoma using MRI scans. It may allow faster and more accurate diagnosis without needing additional tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with glioma, brain metastases, or brain lymphoma.
- You had a complete MRI scan before starting treatment.
- You have not had prior brain surgery or radiation therapy.
- You do not have other brain lesions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze MRI scans of midline brain tumors (gliomas) to help predict how the disease may progress and improve treatment planning. Researchers are collecting data from multiple hospitals to teach an AI system to better understand these tumors.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This trial tests an artificial intelligence tool that automatically spots cancer spread to the brain on MRI scans. It may help doctors find brain metastases faster and more accurately for people with cancer outside the brain.
This trial uses an AI computer program to predict the molecular features of a primary brain tumor (glioma) by looking at tumor tissue images. Your results could help researchers better match glioma subtypes to more tailored care, using information obtained from the surgery sample.
This study uses artificial intelligence to analyze MRI scans of children with brain tumors to help identify the tumor type before surgery. It aims to improve diagnosis and treatment planning.
This trial uses brain scan images (MRI) and tumor tissue tests to predict how long people with primary glioma may live. The goal is to see if the AI prediction can improve planning and care after surgery.
Hear when a new Brain Metastases, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.